XORTX Therapeutics Inc.
Calgary, A0 · CIK 0001729214 · Biotech · Public
Small-molecule therapeutics targeting purine metabolism to reduce uric acid for gout and kidney disease
xortx.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $505K
- 2 Form D · Oct 2024
- 23 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 4
- 0 granted · 4 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201720182019202020212022202320242025
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $505,283 | |
| Private capital raised | Form D · SEC | $1,767,566 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1611 | CELL ORIGINS, LLC | — | — |
| 1612 | GATC HEALTH CORP | — | $981K |
| 1613 | DIVERSE BIOTECH, INC. | — | $669K |
| 1614 | XORTX Therapeutics Inc. | — | $505K |
| 1615 | Stratum Biosciences Inc. | — | $100K |
| 1616 | Generate Biomedicines | — | — |
| 1617 | Provizigen LLC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Allen DavidoffDirector · Executive Officer
- Stacy EvansExecutive Officer
- James FairbairnExecutive Officer
- William FarleyDirector
- Anthony GiovinazzoDirector
- Stephen HaworthExecutive Officer
- Abigail JenkinsDirector
- John MeekisonExecutive Officer
- Alan MooreDirector
- Raymond PrattDirector
- Bruce RowlandsDirector
- Patrick TreanorDirector
- Paul Van DammeDirector
Patents
- Xanthine Oxidase Inhibitor Formulationsapplication
- Compositions And Methods For Diagnosis, Treatment Of And Prevention Of Kidney Diseaseapplication
- Compositions and Methods for Enhancing Anti-Viral Therapiesapplication
- Xanthine Oxidase Inhibitor Formulationsapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.